These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 17521437)

  • 21. [Evaluation of MicroScan Synergies plus Positive Combo 3 Panels for identification and antimicrobial susceptibility testing of Staphylococcus aureus and Enterococcus species].
    Jung H; Lee NY
    Korean J Lab Med; 2010 Aug; 30(4):373-80. PubMed ID: 20805709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS; Streit JM; Fritsche TR; Jones RN
    Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility pattern of Enterococcus species from urinary tract infections.
    Miskeen PA; Deodhar L
    J Assoc Physicians India; 2002 Mar; 50():378-81. PubMed ID: 11922226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotics susceptibility of Streptococcus and Enterococcus: data of Onerba network].
    Vachée A; Varon E; Jouy E; Meunier D;
    Pathol Biol (Paris); 2009 May; 57(3):240-4. PubMed ID: 18343047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci.
    Ligozzi M; Bernini C; Bonora MG; De Fatima M; Zuliani J; Fontana R
    J Clin Microbiol; 2002 May; 40(5):1681-6. PubMed ID: 11980942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Update on the susceptibility of streptococci to antibiotics (enterococci and Streptococcus pneumoniae excluded)].
    Faibis F; Fiacre A; Demachy MC
    Ann Biol Clin (Paris); 2003; 61(1):49-59. PubMed ID: 12604386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of antimicrobial resistance of clinical isolates of enterococci from Beijing and other areas in China].
    Liu GJ; Xu SZ; Ma Y; Li JY
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1049-52. PubMed ID: 12899776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study using standardized methodology for antimicrobial susceptibility of gram-positive cocci isolated from the Puerto Rico Medical Center.
    Rodríguez JL; Vázquez GJ; Bermúdez M; De Orbeta J; García Y; Rivera Y; Robledo IE
    P R Health Sci J; 2002 Dec; 21(4):343-7. PubMed ID: 12572243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms.
    Giani T; Morosini MI; D'Andrea MM; García-Castillo M; Rossolini GM; Cantón R
    Clin Microbiol Infect; 2012 Nov; 18(11):E452-8. PubMed ID: 22909279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria.
    Menozzi MG; Eigner U; Covan S; Rossi S; Somenzi P; Dettori G; Chezzi C; Fahr AM
    J Clin Microbiol; 2006 Nov; 44(11):4085-94. PubMed ID: 17005752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
    Pfaller MA; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):459-65. PubMed ID: 17240105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli.
    O'Hara CM
    J Clin Microbiol; 2006 Mar; 44(3):928-33. PubMed ID: 16517878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid antimicrobial susceptibility testing of gram-positive cocci using Baxter MicroScan rapid fluorogenic panels and autoSCAN-W/A.
    Bascomb S; Godsey JH; Kangas M; Nea L; Tomfohrde KM
    Pathol Biol (Paris); 1991 May; 39(5):466-70. PubMed ID: 1881676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enterococcal infections with special reference to phenotypic characterization & drug resistance.
    Karmarkar MG; Gershom ES; Mehta PR
    Indian J Med Res; 2004 May; 119 Suppl():22-5. PubMed ID: 15232156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.
    Färber J; Moder KA; Layer F; Tammer I; König W; König B
    J Clin Microbiol; 2008 Nov; 46(11):3721-7. PubMed ID: 18845821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance of enterococcal blood isolates at a pediatric care hospital in India.
    Kapoor L; Randhawa VS; Deb M
    Jpn J Infect Dis; 2005 Apr; 58(2):101-3. PubMed ID: 15858289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.
    Malli E; Spiliopoulou I; Kolonitsiou F; Klapsa D; Giannitsioti E; Pantelidi K; Pratti A; Panopoulou M; Grapsa S; Alepopoulou E; Neonakis I; Frantzidou F; Alexiou-Daniel S; Bakola D; Koutsia-Carouzou C; Malamou-Lada H; Zerva L; Vlahaki E; Kartali-Ktenidou S; Anastassiou ED; Petinaki E
    Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens.
    Stamper PD; Cai M; Lema C; Eskey K; Carroll KC
    J Clin Microbiol; 2007 Oct; 45(10):3360-5. PubMed ID: 17704282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.
    Jorgensen JH; Crawford SA
    J Clin Microbiol; 2006 Jun; 44(6):2126-9. PubMed ID: 16757608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.